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A B S T R A C T
Oxidative stress plays an important role in the formation of abdominal aortic aneurysm (AAA), and we have
recently established a causal role of uncoupled eNOS in this severe human disease. We have also shown that
activation of NADPH oxidase (NOX) lies upstream of uncoupled eNOS. Therefore, identification of the specific
NOX isoforms that are required for eNOS uncoupling and AAA formation would ultimately lead to novel
therapies for AAA. In the present study, we used the Ang II infused hph-1 mice to examine the roles of NOX
isoforms in the development of AAA. We generated double mutants of hph-1-NOX1, hph-1-NOX2, hph-1-
p47phox, and hph-1-NOX4. After two weeks of Ang II infusion, the incidence rate of AAA substantially dropped
from 76.5% in Ang II infused hph-1 mice (n=34) to 11.1%, 15.0%, 9.5% and 0% in hph-1-NOX1 (n=27), hph-1-
NOX2 (n=40), hph-1-p47phox (n=21), and hph-1-NOX4 (n=33) double mutant mice, respectively. The size of
abdominal aortas of the four double mutant mice, determined by ultrasound analyses, was significantly smaller
than the hph-1 mice. Aortic nitric oxide and H4B bioavailabilities were markedly improved in the double
mutants, while superoxide production and eNOS uncoupling activity were substantially diminished. These
effects seemed attributed to an endothelial specific restoration of dihydrofolate reductase expression and
activity, deficiency of which has been shown to induce eNOS uncoupling and AAA formation in both Ang II-
infused hph-1 and apoE null animals. In addition, over-expression of human NOX4 N129S or T555S mutant
newly identified in aneurysm patients increased hydrogen peroxide production, further implicating a relation-
ship between NOX and human aneurysm. Taken together, these data indicate that NOX isoforms 1, 2 or 4 lies
upstream of dihydrofolate reductase deficiency and eNOS uncoupling to induce AAA formation. These findings
may promote development of novel therapeutics for the treatment of the disease by inhibiting NOX signaling.
1. Introduction
Abdominal aortic aneurysms (AAA) occur in adults older than 65
years old, and the number of deaths in U.S. attributed to ruptured
AAAs increased from 99,600 in 1990 to 151,500 in 2013 [1,2]. One of
the key features of AAA is vascular wall remodeling associated with
significant production of reactive oxygen species (ROS) [3]. We have
recently established a causal role of eNOS uncoupling in the formation
of AAA [4,5,6]. Infusion of Ang II into hyperphenylalaninemia (hph)-1
mice induced a three-fold increase in the uncoupling activity of eNOS,
resulting in 79% of AAA development within two weeks; and recou-
pling of eNOS by folic acid administration effectively inhibited the
development of AAA [5,6]. Uncoupling of eNOS is also responsible for
AAA formation in Ang II infused apoE null mice [4].
We have shown that NADPH oxidase (NOX) activation lies up-
stream of eNOS uncoupling in endothelial cells [7], diabetic mice [7],
and ischemia/reperfusion-injured heart [9]. The NOX family members
expressed in the cardiovascular system include NOX1, 2, 4, and 5 [10–
13]. It seems that different NOX isoforms are involved in the
pathogenesis of different cardiovascular disorders. For example,
NOX1, but not NOX2 or NOX4, underlies endothelial dysfunction in
streptozotocin-induced type 1 diabetes mellitus [15]. While protective
laminar shear stress assembles NOX2-p47phox at basal levels to
increase eNOS phosphorylation and nitric oxide (NO) production,
atherogenic oscillatory shear stress activates NOX1-NOXO1 complex
to uncouple eNOS and sustain oxidative stress [16]. On the other hand,
NOX4 but not NOX1/2, is activated to mediate eNOS uncoupling in
ischemia/reperfusion (I/R)-injured heart, and involved in cardiac
damage and remodeling [9,17,18]. NOX4 upregulation also correlates
with the presence of atrial fibrillation in patients, and promotes cardiac
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arrhythmic phenotype in a zebrafish model [19,20]. In addition, it has
been shown that NOX1/2 inhibition through genetic deletion of
p47phox attenuated atherogenesis in young apoE null mice [21].
In the present study we examined effects on AAA formation of
genetic deletion of different NOX isoforms. Hph-1 mice were crossed
with NOX1, NOX2, p47phox, and NOX4 knockout mice to generate
double mutants. Inhibition of any NOX isoforms or p47phox signifi-
cantly reduced the incidence of AAA while abolishing pathophysiolo-
gical features. This was associated with restored eNOS coupling
activity. Two human NOX4 mutants N129S and T555S newly identified
in aneurysm patients had increased H2O2 production. These data
suggest that inhibition of NOX signaling may prove to be an effective
therapeutic strategy for aortic aneurysms.
2. Methods
2.1. Reagents
Unless otherwise noted, all chemicals were purchased from Sigma-
Aldrich (St Louis, MO, USA) in the highest purity. Isoflurane was
obtained from Piramal Healthcare (Bethlehem, PA, USA). Heparin
sodium injection solution was from Sagent Pharmaceuticals
(Schaumburg, IL, USA).
2.2. Production of double mutant animals
All animals and experimental procedures were approved by the
Institutional Animal Care and Usage Committee at the University of
California, Los Angeles. Homozygote hph-1 mice were maintained as
described before [5,6]. NOX1-null founder mice were generously
provided by Dr. Karl-Heinz Krause from the University of Geneva
[22]. NOX2-null and p47phox-null founder mice were originally
purchased from Jackson Laboratory (Bar Harbor, Maine, strain
002365 and 004742, respectively). NOX4-null founder mice were
kindly provided by Dr. Junichi Sadoshima from the Rutgers
University. Double mutants of NOX1, NOX2, p47phox, or NOX4 with
hph-1 animals were generated in-house by breeding male NOX1,
NOX2, p47phox, and NOX4 knockouts with female hph-1 animals.
The pups were genotyped using PCR, and double mutants were used
for all future breeding.
2.3. Genotyping of the double mutant animals
Genomic DNA was isolated from tail clips as per standard protocol,
using protease K (Invitrogen, Carlsbad, CA, USA) to digest the tail,
followed by elution of the DNA by isopropanol. For the NOX1 KO, the
PCR primers used were: 5′-ACGGGCACA TGTGTAAGACTCACC-3′, 5′-
GCCTGCAACTCCCCTTATGGTCA-3′, and 5′-CTACCAGGCCAATCTC-
TCTGTTTCCA-3′. The PCR amplification was performed using the
conditions of 95 °C for 5 min, followed by 34 cycles of 95 °C for 15 s,
61 °C for 15 s and 72 °C for 48 s. For the NOX2 KO, the PCR primers
used were 5′-AAGAGAAACTCCTCTGCTGTGAA-3′, 5′-CGCACTGGAA-
CCCCTGAGAAAGG-3′, 5′-GTTCTAATTCCATCAGAAGCTTATCG-3′.
The PCR amplification was performed using the conditions of 95 °C
for 15 min, followed by 35 cycles of 94 °C for 20 s, 58 °C for 60 s and
72 °C for 45 s. For the p47phox KO, the PCR primers used were : 5′-
TGGAAGAAGCTGAGAGTTGAGG-3′ and 5′-TCCAGGAGCTTATGAAT-
GACC-3′. The PCR amplification was performed using the conditions of
95 °C for 15 min, followed by 35 cycles of 94 °C for 30 s, 55 °C for 30 s
and 72 °C for 30 s. For NOX4 KO , the PCR primers used were 5′-
CATCTTCTTGTTTTTATCCAATTTAAATTTAG-3′ and 5′-GCAGATCT-
CAAACACAGAATTAATCTG-3′. The PCR amplification was performed
using the conditions of 95 °C for 3 min, followed by 30 cycles of 94 °C
for 60 s, 50 °C for 60 s and 72 °C for 30 s. For the hph-1, the primers
used were: 5′-AGGCTGCCCATAAAAGGG-3′ and 5′-GTTTGTGCTAA-
TGTTCTCATCTGG-3′. The PCR amplification was performed using the
conditions of 95 °C for 15 min, followed by 35 cycles of 94 °C for 20 s,
58 °C for 60 s and 72 °C for 45 s [5,6] .
2.4. Osmotic pump infusion of Ang II
Animals were anesthetized with isoflurane in an isoflurane cham-
ber, and then moved to a nose cone supplying 1.5–2% isoflurane to
maintain the anesthetic state. A small area between the shoulder blades
in the back of the mice was removed of hair, and then disinfected with
an iodine solution. A small incision was made at the site, followed by
the insertion of an osmotic pump (Alzet, model 2002, Cupertino, CA,
USA) containing Ang II (0.7 mg/kg/day) in a delivery solution
(3.8 mL H2O, 120 µl 5 M NaCl, 40 µl acetic acid) under the skin to
the left flank. Surgical staples were used to close the site. The animals
were placed in a heated chamber for recovery.
2.5. Ultrasound imaging of abdominal aorta
Animals were anesthetized (0.6–0.8% isoflurane in 95% oxygen,
heart rate: 430–450 beats/min) with isoflurane and placed on a heated
table that monitors electrocardiography (ECG). Heart rate was main-
tained above 400 bpm while keeping the animal sufficiently anesthe-
tized (1.5–2% isoflurane). The hair in the abdomen was removed using
a hair removal lotion (Veet, Reckitt Benckiser, Slough, United
Kingdom). Pre-heated ultrasound transmission gel was applied over
the cleaned abdomen area. An ultrasonic probe (Visualsonics 2100,
MS400, 30 MHz. FUJIFILM VisualSonics, Inc. Toronto, Ontario,
Canada) was placed onto the gel to visualize the abdominal aorta on
the transverse plane. Doppler mode was used to detect pulsatile flow to
confirm the location of the aorta. Consistent localization of the imaging
area was ensured by imaging the aorta immediately superior to the left
renal artery. For animals that have abdominal aneurysms, the mea-
surement was made at the site of maximal aortic diameter.
2.6. Tissue collection
After 2 weeks of Ang II infusion, animals were euthanized with CO2.
The aortas were rapidly removed from the body, rinsed with ice cold
modified Krebs/HEPES buffer (KHB: 99 mmol/L NaCl; 4.7 mmol/L
KCl; 1.2 mmol/L MgSO4; 1.0 mmol/L KH2PO4; 2.5 mmol/L CaCl2;
25 mmol/L NaHCO3; 5.6 mmol/L D-glucose; 20 mmol/L NaHEPES),
and cleaned of connective tissue and fat on ice. Determination of AAA
incidence was made using ultrasound measurement and/or inspection
of the abdominal aorta post-mortem. A small section (about 2 mm) of
the suprarenal aorta was removed for histology. This small section was
fixed in 10% formalin overnight, followed by a 24 h incubation in 10%
sucrose. The tissues were then embedded in paraffin and sliced at 5 µm.
2.7. Determination of aortic superoxide production using electron
spin resonance
Aortic superoxide was measured by ESR as previously described
[4,5,6,23,24]. Briefly, freshly isolated aortas were homogenized on ice
in lysis buffer containing 1:100 protease inhibitor cocktail, and
centrifuged at 12,000g for 15 min. Protein content of the supernatant
was determined using a protein assay kit (Bio-Rad, Irvine, CA, USA).
Five µg of protein was mixed with ice-cold and nitrogen bubbled
Krebs/HEPES buffer containing diethyldithiocarbamic acid (5 µmol/
L), deferoxamine (25 µmol/L), and the superoxide specific spin trap
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH, 500 µmol/L,
Axxora, San Diego, CA, USA). The mixture was then loaded into a
glass capillary (Kimble, Dover, OH, USA), and assayed using the ESR
spectrometer (eScan, Bruker, Billerica, MA, USA) for superoxide
production. A second measurement was taken with the addition of
PEG-SOD (100 U/mL) for the determination of background. For the
assessment of eNOS uncoupling, a third measurement was made with
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the addition of L-NAME (100 µmol/L). ESR settings used were: Center
field, 3480; Sweep width, 9 G; microwave frequency, 9.78 GHz;
microwave power, 21.02 mW; modulation amplitude, 2.47 G; 512
points of resolution; receiver gain, 1000.
2.8. Determination of aortic NO bioavailability using electron spin
resonance
Aortic NO production was also measured using ESR as previous
described [4,5,6,23,24]. Briefly, freshly isolated aortas were cut into
2 mm rings, and then incubated in freshly prepared NO specific spin
trap trap Fe2+(DETC)2 (0.5 mmol/L) in nitrogen bubbled, modified
Krebs/HEPES buffer (as described above) at 37°C for 60 min, in the
presence of calcium ionophore A23187 (10 μmol/L). The aortic rings
were then snap frozen in liquid nitrogen and loaded into a finger Dewar
for measurement with ESR. The instrument settings were as the
followings: Center field, 3440; Sweep width, 100 G; microwave fre-
quency, 9.796 GHz; microwave power 13.26 mW; modulation ampli-
tude, 9.82 G; 512 points of resolution; and receiver gain 356.
2.9. Determination of aortic H4B bioavailability with HPLC
Aortic H4B and its oxidized species were measured using HPLC as
previously described [4,5,6,23,24]. Briefly, freshly isolated aortas were
lysed in H4B lysis buffer (0.1 mol/L phosphoric acid, 1 mmol/L EDTA,
10 mmol/L DL-Dithiothreitol), centrifuged at 12,000g for 3 min, and
the lysates were subjected to differential oxidation in acidic (0.2 mol/L
trichloroacetic acid with 2.5% I2 and 10% KI) and alkalytic (0.1 mol/L
NaOH with 0.9% I2 and 1.5% KI) solutions. After centrifugation, 10 µl
of the supernatant was injected into a HPLC system equipped with a
fluorescent detector (SHIMADZU AMERICA INC, Carlsbad, CA, USA).
Excitation and emission wavelengths of 350 nm and 450 nm were used
to detect H4B and its oxidized species. H4B concentration was
calculated as previously described [25,26].
2.10. Isolation of endothelial cells from aorta
Endothelial cells (ECs) were isolated from aortas as previously
described [4,5,6]. Briefly, freshly isolated aortas were cut into small
sections (about 2 mm) and digested in PBS containing collagenase
(0.6 mg/mL) for 20 min at 37 °C. The aortic rings were then gently
shaken in the digestion buffer to remove the ECs. The ECs were then
collected via centrifugation at 1000g for 3 min at 4 °C. Both the
denuded rings and ECs were lysed with lysis buffer for subsequent
analyses of DHFR protein expression and activity.
2.11. Western blotting
Western blotting was performed as per standard protocols using
10% SDS/PAGE gels and transferring to nitrocellulose membranes.
After 1 h blocking in PBS with 0.1% Tween-20 and 5% (w/v) non-fat
dry milk, the membrane was then incubated with primary antibodies
for DHFR (1:500, Novus Biologicals, Littleton, CO, USA), actin
(1:3000, Sigma-aldrich, St Louis, MO, USA), and eNOS (1:2000, BD,
Franklin Lakes, NJ, USA).
2.12. Determination of endothelial DHFR activity with HPLC
DHFR activity was measured from isolated EC or denuded aortic
ring lysates as previously described [4,23]. Briefly, lysates were
incubated in a DHFR assay buffer (0.1 mol/L potassium phosphate
dibasic, 1 mmol/L DTT, 0.5 mmol/L KCl, 1 mmol/L EDTA, and
20 mmol/L sodium ascorbate at pH 7.4) with NADPH (200 µmol//L)
and the substrate dihydrofolate (50 µmol/L) at 37 °C for 20 min in the
dark. The product of the reaction, tetrahydrofolate (THF), was mea-
sured using a HPLC system (SHIMADZU AMERICA INC, Carlsbad,
CA, USA) with a C-18 column (Alltech, Deerfield, MA, USA) using
water based mobile phase consisting of 7% acetonitrile and 5 mmol/L
of potassium phosphate dibasic at pH 2.3. The signal was detected
using a fluorescent detector at 295 nm excitation and 365 nm emission.
The THF content was calculated against a standard curve prepared by
using THF solutions in assay buffer. Data are presented as nmol
production of THF per min per mg protein.
2.13. Construction of NOX4 mutant plasmids
Full length coding region of human NOX4 (NM_016931, isoform A
of human NOX4) in pCMV6-hNOX4 was purchased from OriGene
(Rockville, MD, USA). Mutations of N129S, P437H and T555S were
generated by PCR based site-directed mutagenesis (KOD Hot Start,
Novagen, Darmstadt, Germany). All of the plasmids were confirmed by
sequencing.
2.14. Determination of H2O2 Levels by Amplex Red Assay
HEK293T were cultured in media Dulbecco's Modified Eagle
Medium (DMEM) containing 10% fetal bovine serum (FBS). One day
after seeding in 60 mm dish, 6 µg of human NOX4 WT and mutant
(P473H, N129S, and T555S) plasmids were transfected into HEK293T
cells using lipofectamine 2000 as per manufacturer's instructions
(Invitrogen, Carlsbad, CA, USA). Forty-eight hrs after transfection,
cells were harvested in Krebs-Ringer buffer and mixed with Amplex
Red reaction buffer as previously described [9]. Each sample was
treated with or without PEG-catalase (100 U/mL). The samples were
incubated at 37°C for 1 h in the dark, and then centrifuged at 2,500g
for 5 min. The supernatants were loaded to a 96 well plate, and then
measured using a BioTek fluorescent plate reader at 530 nm excitation
and 590 nm emission respectively. Freshly prepared H2O2 standards
were used to calculate the amount of H2O2 produced by the samples.
2.15. Statistical analysis
All statistical analysis was carried out with the Prism software.
Comparisons between multiple groups are done using the one-way
ANOVA test with a statistical threshold of 0.05, followed by the
Newman-Keuls post-hoc test. Comparisons of the incidence rates were
done using a contingency table, also with a statistical threshold of 0.05.
3. Results
3.1. Genetic knockout of NOX1, NOX2, p47phox, or NOX4 prevented
AAA development in Ang II infused hph-1 mice
We firstly crossed hph-1 mice with NOX1, NOX2, p47phox, or
NOX4 knockout mice to generate new double mutant mice. To
investigate the role of NOX signaling in AAA formation, these mice
were infused with Ang II for two weeks. In the hph-1 group, 76.5% of
the animals developed AAA, which is comparable to our previous
reports [5,6]. In contrast, only 11.1%, 15.0%, and 0% of the animals
developed AAA in hph-1-NOX1, hph-1-NOX2, and hph-1-NOX4
double mutant mice group respectively (Fig. 1). Moreover, hph-1
animals that also have p47phox (a cytosolic regulatory subunit of
NOX1 and NOX2 [21]) deficiency developed AAA in 9.5% of the
animals received Ang II infusion. These data suggest that activation of
NOX isoforms is involved in Ang II induced AAA formation in hph-1
mice.
3.2. NOX1, NOX2, p47phox, or NOX4 knockout inhibited abdominal
aortic expansion and abolished extensive medial elastin breakdown
and adventitial remodeling in Ang II infused hph-1 mice
Ultrasound images were taken to examine the size of the abdominal
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aortas in the double mutant animals before Ang II infusion and at the
end of the 2 week infusion. Ang II infusion for two weeks resulted in
significant expansion of abdominal aortas (Fig. 2). However, the
abdominal aortas of hph-1-NOX1, hph-1-NOX2, hph-1-p47phox, and
hph-1-NOX4 double mutant animals were substantially smaller than
those of hph-1 alone (hph-1-NOX1 with Ang II: 1.31 ± 0.08 mm2, hph-
1-NOX2 with Ang II: 1.44 ± 0.08 mm2, hph-1-p47phox with Ang II:
1.60 ± 0.24 mm2, hph-1-NOX4 with Ang II: 1.38 ± 0.06 mm2 vs. hph-1
with Ang II: 3.12 ± 0.27 mm2, p < 0.001). Moreover, as shown in Fig. 3,
H& E staining from the abdominal aortic sections demonstrated that
Ang II infusion led to dramatic medial elastin fiber breakdown and
adventitial hypertrophy in hph-1 mice, which were largely absent in
hph-1-NOX1, hph-1-NOX2, hph-1-p47phox, and hph-1-NOX4 double
mutant animals. These results confirmed that inhibition of NOX
signaling might be an effective approach to attenuate AAA formation.
3.3. NOX1, NOX2, p47phox, or NOX4 knockout improved NO and
H4B bioavailabilities, reduced superoxide production, and recoupled
eNOS in Ang II infused hph-1 mice
Our previous studies have established a novel causal role of eNOS
uncoupling in AAA formation [4,5,6,23,24]. In addition, there are
evidences that Ang II transiently activates NOXs, resulting in uncou-
pling of eNOS in endothelial cells [7,8]. To explore the mechanisms
whereby NOX signaling mediates AAA formation, we firstly measured
#
AAA No AAA
826IIgnA+1-hph
hph-1-NOX1 + Ang II 3 24
hph-1-NOX2 + Ang II 6 34
hph-1-p47phox + AngII 2 19
hph-1-NOX4 + AngII 0 33
Fig. 1. NOX1, NOX2, p47phox, or NOX4 knockout greatly reduced the
incidence of AAA in Ang II-infused hph-1 mice. The top panel shows the
percentage of AAA in each strain of mice subjected to Ang II infusion, while the bottom
panel shows the actual numbers of animals for each group. The incidence of AAA was
greatly reduced from 76.5% in AngII-infused hph-1 animals to 11.1%, 15.0%, 9.5% and
0% in hph-1-NOX1, hph-1-NOX2, hph-1-p47phox, and hph-1-NOX4 double mutant
animals, respectively. #p < 0.001.
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Fig. 2. Hph-1-NOX1, hph-1-NOX2, hph-1-p47phox, and hph-1-NOX4 double mutant mice had inhibited abdominal aortic expansion in response to Ang II.
Representative ultrasound images (top panel) and grouped data (bottom panel) of abdominal aortas of Ang II-infused animals. The prominent expansion of the abdominal aorta
observed in the Ang II-infused hph-1 animals was substantially attenuated in hph-1-NOX1, hph-1-NOX2, hph-1-p47phox, and hph-1-NOX4 double mutant mice, n=5–9, *p < 0.05, #p
< 0.001.
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aortic NO production from different double mutants infused of Ang II
for 2 weeks. The results show that these four strains of double
knockouts had significantly improved NO production (Fig. 4A), and it
was recovered back to the similar level in hph-1 mice without Ang II
infusion as observed previously [5].
Aortic superoxide production with or without L-NAME, which is an
inhibitor of NOS activity, was further measured using ESR. The white
bars in Fig. 4B show that all four strains of the double mutants had
reduced superoxide production compared to Ang II infused hph-1
animals, and this is to the baseline in hph-1 mice without Ang II
infusion as previously reported [5]. L-NAME was used to assess the
coupling state of eNOS. When eNOS is coupled and functional, the
addition of L-NAME will inhibit NO and increase superoxide. However,
if eNOS is uncoupled and producing superoxide, the addition of L-
NAME will reduce total superoxide production. Therefore, the relative
change between the two measurements shows the coupling state of
eNOS of the sample. The L-NAME measurements are shown as black
bars in Fig. 4B. For hph-1 animals under Ang II infusion, the addition
of L-NAME greatly reduced superoxide production, which suggests
uncoupling of eNOS as observed previously [5]. The addition of L-
NAME to the aortic samples of double mutants, however, resulted in
very little change in superoxide production, suggesting almost com-
plete recoupling of eNOS in these groups.
To further examine the coupling state of eNOS, H4B, the critical
cofactor that determines the coupling/uncoupling switch of eNOS, was
measured from the aortas of animals after 2 weeks of Ang II infusion,
which led to H4B reduction in hph-1 mice at baseline (1.87 ± 0.25
pmol/mg protein to 0.99 ± 0.11 pmol/mg) [5]. The results in Fig. 4C
showed that aortas from the four double mutants had significantly
higher H4B levels compared to hph-1s alone, suggesting an improve-
ment in the coupling state of eNOS in these animals. This recovery is
complete (~2 pmol/mg protein) to the baseline in hph-1 mice without
Ang II infusion as documented previously and described above [5].
Therefore, these data confirmed that NOX isoforms take part in the
regulation of eNOS coupling state to mediate AAA formation.
3.4. Double mutant of hph-1 with NOX1, NOX2, p47phox, or NOX4
had preserved endothelial specific DHFR expression and activity in
response to Ang II infusion
Our previous studies have shown that the reduction of H4B in Ang
II infused hph-1 and apoE null mice is consequent to an endothelial
specific deficiency in DHFR, a salvage enzyme for H4B [4,5,6]. Here, we
examined whether the improvement in H4B levels in the double mutant
mice was a result of improved endothelial DHFR function. We first
measured DHFR protein levels in isolated aortic endothelial cells (ECs)
and EC-denuded aortic rings from mutant mice infused with Ang II. As
shown in Fig. 5A–C, eNOS was detected only in the fractions of ECs,
but not in the EC-denuded aortic rings. The DHFR protein abundance
in the ECs of the four double mutant mice was significantly higher than
those of hph-1s that displayed an EC-specific deficiency (5), while no
significant changes were observed in the EC-denuded rings. In addi-
tion, data on DHFR activities mirrored the responses of DHFR protein
expression (Fig. 5D). These results demonstrated an intermediate role
of endothelial specific DHFR deficiency in NOX isoform-dependent
eNOS uncoupling and consequent AAA formation.
hph-1-NOX4hph-1 hph-1-NOX1 hph-1-NOX2 hph-1-p47phox
Fig. 3. The extensive elastin breakdown and adventitial remodeling of the abdominal aorta in AngII-infused hph-1 mice was substantially attenuated in hph-1-
NOX1, hph-1-NOX2, hph-1-p47phox, and hph-1-NOX4 double mutant mice. Shown are representative histological images of the abdominal aortas from Ang II infused hph-
1, hph-1-NOX1, hph-1-NOX2, hph-1-p47phox, and hph-1-NOX4 animals. The results show that the breakdown of the elastin fibers and enlargement of the adventitial layer in the
abdominal aortas of the AngII-infused hph-1 animals were eliminated in the hph-1-NOX1, hph-1-NOX2 and hph-1-p47phox, and hph-1-NOX4 animals.
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3.5. Two human NOX4 mutants N129S and T555S identified in
aneurysm patients had increased H2O2 production
In an effort to screen for genetic variants in aneurysm patients
(Supplemental for detailed methods), we have identified 2 novel
mutants in NOX4 gene, N129S and T555S. N129S locates in the
extracellular loop between the transmembrane domains III and IV.
T555S locates in the cytoplasmic COOH terminus. We next generated
WT NOX4, P437H (dominate negative mutation for NADPH binding),
N129S, and T555S mutant plasmids, and transfected into HEK293T
cells. Productions of H2O2 from these cells were determined using
Amplex Red Assay ( Fig. 6). The increased H2O2 production induced by
human WT NOX4 overexpression, was effectively blocked in the P437H
mutant group (P437H: 0.87 ± 0.24 nmole/mg protein vs. hNOX4: 2.84
± 0.43 nmole/mg protein, p < 0.05) Of note, both N129S and T555S
mutations resulted in marked increase in H2O2 production compared
to the WT group (N129S: 5.25 ± 0.94 nmole/mg protein vs. hNOX4, p
< 0.01; T555S: 4.65 ± 0.64 nmole/mg protein vs. hNOX4, p < 0.05).
Taken together, these data indicate that two human NOX4 mutants
N129S and T555S might be involved in aneurysm development
through producing more H2O2, which functions as an intermediate to
induce endothelial DHFR deficiency and eNOS uncoupling [7].
4. Discussion
In the present study, we examined the role of the different isoforms of
NOX in AAA formation in Ang II infused hph-1 mice. Genetic knockout
of NOX1, NOX2, p47phox, or NOX4 in hph-1 animals prevented
formation of AAA, reflected in reduced abdominal aortic expansion
and recovery of extensive elastin breakdown and adventitial remodeling.
Furthermore, the double mutant mice had improved aortic NO produc-
tion and reduced superoxide production, due to restored eNOS coupling
activity, which is consequent to the endothelial specific improvement in
DHFR protein abundance and activity. In addition, human NOX4
mutations N129S and T555S producing more H2O2 might be the reason
for aneurysm development in some patients. These findings establish
NOX isoforms as novel targets for the treatment of aortic aneurysms.
NOXs are one of the major sources of oxidative stress in the blood
vessels. Different isoforms separately or together display different
functions. NOX1 has been shown to be involved in diabetic endothelial
dysfunction and endothelial cell response to atherogenic oscillatory
shear stress [15,16]. On the contrary, NOX4 plays a critical role in
Fig. 4. NOX1, NOX2, p47phox, or NOX4 knockout improved NO and H4B bioavailabilities, reduced superoxide production, and recoupled eNOS in Ang II infused hph-1 mice. (A)
Aortic nitric oxide (NO) production was determined from aortic segments using electron spin resonance (ESR). Double mutants of hph-1 with NOX1, NOX2, p47phox, or NOX4
corrected the decline in aortic NO production in Ang II-infused hph-1 animals. n=4, *p < 0.05, **p < 0.01. (B) Total superoxide production was measured from aortic homogenates using
ESR. eNOS uncoupling activity was assessed by comparing measurements with and without the addition of L-NAME, a NOS inhibitor, n=4–7, *p < 0.05. A reduction in superoxide
production with L-NAME indicates that NOS is uncoupled and producing superoxide. The eNOS uncoupling phenotype in hph-1 mice was prevented in all of the double mutant mice.
(C) Aortic H4B bioavailability was determined by HPLC, and the deficiency of H44B in hph-1 mice was corrected in all of the double mutant mice. n=5, *p < 0.05, **p < 0.01.
K.L. Siu et al. Redox Biology 11 (2017) 118–125
123
cardiac I/R injury [9]. Therefore, these isoforms are not functionally
redundant. In the condition of Ang II infusion, NOX2 plays a major
role in mediating Ang II-induced cerebral endothelial dysfunction [27].
However, both NOX1 and NOX2 were found involved in Ang II
induced hypertension [28–31].
We have recently established a novel mouse model of AAA that has a
high incidence rate of 79% two weeks post Ang II infusion into hph-1
mice [5,6]. Approximately 14% of the animals died of ruptured
aneurysms within the short period of two weeks. This model is therefore
associated with high morbidity and mortality. It is more severe than
other currently known models, such as apoE null and LDLR null mice
that require four weeks of Ang II infusion to develop aneurysms, and the
animals do not die of ruptured aneurysms during the study period
[4,32,33]. In the hph-1 model, Ang II induced more than a threefold
increase in eNOS uncoupling activity. Our recent work also showed that
NOX4 activation precedes eNOS uncoupling in I/R injured heart [8]. In
addition, NOX activity has been implicated in AAA generation [34–37].
Therefore, in this study, we prefer to use this new model to investigate
whether NOX isoforms are involved in the formation of AAA. Indeed,
deletion of NOX1, NOX2, p47phox, or NOX4 conferred a protective
effect against AAA formation in Ang II infused hph-1 mice.
Our result is consistent with previous findings that deletion of
p47phox attenuates Ang II-induced AAA formation in apoE null mice
[37]. As a cytosolic regulatory subunit, p47phox is required for the
activation of both NOX1 and NOX2 [15,21,38,39]. Therefore, p47phox
deletion also means inactivation of NOX1 and NOX2, which resulted in
even more potent prevention of AAA formation. Although previous
studies have mostly revealed a role of NOX4 in cardiac diseases [9,17–
19], our data for the first time demonstrated an important role of
NOX4 in Ang II induced AAA development. It turns out inhibition of
any of the NOX isoforms attenuates AAA by recoupling of eNOS,
characterized by improved aortic NO and H4B bioavailabilities and
reduced superoxide production (Fig. 4). Indeed, the extent of eNOS
uncoupling but not just the state, dictates the development of AAA,
because eNOS is uncoupling at baseline in hph-1 mice which is
Fig. 5. NOX1, NOX2, p47phox, or NOX4 knockout markedly improved endothelial DHFR protein expression and activity in Ang II-infused hph-1 mice. (A-B)
Representative Western blots of DHFR, actin, and eNOS from aortic endothelial cells (ECs) and EC-denuded aortas of Ang II-infused hph-1, hph-1-NOX1, hph-1-NOX2, hph-1-
p47phox, and hph-1-NOX4 animals; (C) Grouped quantitative data of A-B, n=3, *p < 0.05. (D) DHFR activities measured from isolated aortic ECs and the EC-denuded aortas, n=3–5,
*p < 0.05.
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Fig. 6. Two human NOX4 mutants N129S and T555S identified in aneurysm
patients had increased H2O2 production.Whole-exome sequencing was performed
in Chinese Han patients with aneurysm. Through variants evaluation and Sanger
sequencing, two human NOX4 mutants N129S and T555S were identified. NOX4
mutations of N129S and T555S, as well as the kinase inactive form of P437H with
deficiency in NADPH binding, were generated by PCR based site-directed mutagenesis.
HEK293T cells were transfected with indicated plasmids. Forty eight hrs later, cells were
harvested for determination of for H2O2 production using the Amplex Red assay. n=4, *p
< 0.05, **p < 0.01.
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however well compensated, and Ang II infusion induces a threefold
increase in eNOS uncoupling activity [5,6]. Therefore, recoupling of
eNOS could represent an effective therapeutic approach for AAA
following NOX inhibition, as afforded by oral folic acid administration
[5,40]. The potential interactions among different NOX isoforms in the
pathogenesis of AAA is of particular interest for future investigation.
In conclusion, in this study we examined the role of NOX isoforms
in AAA using Ang II infused hph-1 mice. Animals that had the double
mutant of hph-1 and NOX1, NOX2, p47phox or NOX4 had reduced
AAA incidence and abdominal aortic expansion after Ang II infusion.
Further, the double mutant animals had reduced superoxide produc-
tion, improved NO and H4B bioavailabilities, and restored eNOS
coupling activity compared to hph-1 mice, and this effect is consequent
to preserved DHFR function in the endothelium. Moreover, two NOX4
mutants existing in aneurysm patients (N129S and T555S) had
increased H2O2 production. These findings prove that restoration of
eNOS coupling activity by the inhibition of NOX signaling may serve as
a novel therapeutic strategy for the management of AAA.
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